Novartis Investigative Site

Eindhoven, Netherlands 5631 BM

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Heart Failure With Reduced Ejection Fraction

Studies at this site

• Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early